CatalystWireBeta

UK small-cap RNS · 21 Apr 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.

Sort: Newest · Largest companies
  1. 11:35
    Annual Report and Accounts and Notice of AGM Results
    STV Group plc LEI: 21380075GOOTTBDNDJ58 21 April 2026 Annual Report and Accounts and Notice of Annual General Meeting
    −0.2% on the day
  2. 11:19
    Availability of Annual Report and Notice of AGM Results
    The Company's Annual General Meeting ("AGM") is to be held at The Bradfield Centre Auditorium, 184 Cambridge Science Park Milton Rd, Milton, Cambridge CB4 0GA on 04 June 2026 at 8.30.a.m.
    −3.0% on the day
  3. 10:43
    Annual Report and Accounts and Notice of AGM Results
    Following the release on 31 March 2026 of the Company's financial results for the year ended 31 January 2026, the Company announces it has today published its annual report and accounts for the year ended 31 January 2026 (the "Annual Report and Accounts").
    −1.7% on the day
  4. 09:00
    Annual Report and Accounts and Notice of AGM Results
    2025 Annual Report and Financial Statements ('the Annual Report') and
    −1.1% on the day
  5. 07:00
    2025 Annual Report and Notice of AGM Results
    The Annual General Meeting ('AGM') will be held at 10:00am British Summer Time (BST) on Thursday, 21 May 2026 at the offices of Burges Salmon LLP, 6 Great New Street, London, EC4A 3BN, United Kingdom.
    +0.0% on the day
  6. 07:00
    S&U SUS £231m
    Final Results Results
    · Profit before tax ("PBT"): £31.8m (2025: £24.0m)
    ahead of expectationsfirst in 6 months −3.5% on the day
  7. 07:00
    BAWAG Q1 2026 Results & Update Results
    BAWAG's Q1 results restate the recommended all-cash offer agreed on 14 Apr 2026 and set out how it will fund it, with no change to terms; conditions are still outstanding.
    in line +0.9% on the day
    Moved: Offer for the company: Recommended cash offer agreed; conditions outstanding → Recommended cash offer agreed; conditions outstanding
  8. 07:00
    Final Results Results
    Final Results for the year ended 31 December 2025
    in linefirst in 6 months −8.5% on the day
  9. 07:00
    Final Results Results
    FY25 delivered in line with market expectations, with underlying profit up on a full year of acquisitions, but statutory loss, higher net debt and a cautious 2026 outlook temper it.
    in lineoutlook mixedfirst in 11 months −13.1% on the day
    Moved: new: Order book and 2026 demand – Order book flat in Q1; 66% cover · new: Net debt and covenants – Net debt £47.9m; facility to Sept 2027 · new: Acquisition integration and cost savings – Integration progressing; Q1 2026 cost actions
  10. 07:00
    Final Results Results
    Revenue rose 17% to £41.3m, EBITDA margin widened to 22% and net debt fell to £12.3m. But revenue and EBITDA (£9.2m) came in below the £42.6m and £10.0m expectations noted in November, so 'in line' does not hold. No final dividend is proposed.
    New CEO / reset £41.3m · 375% of mcapin lineoutlook mixedfirst in 7 months +6.7% on the day
    Moved: Cost reduction and integration: Actions under way, savings expected FY26 → Progress reported; FY25 margin up to 22% · new: New management team reset – CEO and CFO in post; strategy being developed
  11. 07:00
    Results of CLN fundraise Results
    Acceler8 Ventures Plc (LSE: AC8, "AC8" or the "Company"), the Main Market listed acquisition company, announces that, further to the announcement made on 8 April 2026 ("CLN Announcement"), AC8 has successfully secured funding commitments of £1,000,000 through …
  12. 07:00
    Final Results Results
    FY26 Adjusted EBITDA turned to a £0.3m profit from a £2.3m loss, ahead of the break-even indicated in the pre-close update, after the £4m cost programme; net cash was £3.0m.
    Sale process / strategic review ahead of expectationsoutlook positivefirst in 7 months +0.0% on the day
    Moved: Formal Sale Process: Formal Sale Process just launched; no active offer talks → Ongoing; no offer or price yet · Cost reset and return to growth: Cost savings delivered; board now seeking a sale → £4m cost saving complete; EBITDA profitable
  13. 07:00
    Final Results Results
    The loss widened to £0.65m from £0.30m, but cash rose to £2.50m after the November raise. The gross resource gain to 1,485,000oz mostly repeats earlier drilling announcements.
    Project milestones outlook positivefirst in 6 months −2.3% on the day
    Moved: Bibemi Exploitation Licence application: Updated report and PEA submitted; negotiations ongoing → Amended technical report submitted; decision awaited in 2026
  14. 07:00
    Final Results Results
    FY25 revenue was £11.6m (slightly above the c.£11.5m flagged in December) but moved to an adjusted EBITDA loss of £0.4m. Branded sales fell 8% and net cash stayed negative.
    Sale process / strategic review outlook positivefirst in 6 months +0.0% on the day
    Moved: OEM partner component supply disruption: Supply resuming after quality issue → Supply constraint resolved (closed) · Weak elective surgery demand: Q4 sales hit by flu and NHS strikes → Q1 2026 sales positive; strike impact ongoing · new: Strategic review for shareholder value – Board reviewing options
  15. 07:00
    Results for the year ended 31 December 2025 Results
    Continuing revenue rose 11% and the loss narrowed slightly, but cash fell to €40,732 and a going-concern material uncertainty is flagged, so the position stays fragile.
    Balance-sheet stress / refinancing outlook mixedfirst in 7 months +0.0% on the day
    Moved: Chair succession: Formal search for new Chair started → Search ongoing; interim Chair leaves 11 May · new: Going concern and funding – Material uncertainty; Board engaging funding partners
  16. 07:00
    Results for the year ended 31 December 2025 Results
    Revenue fell 15.4% and underlying profit before tax dropped to £4.1m from £10.8m. Yate closure costs cut reported profit to £1.3m, and the dividend was cut to 11.0p from 25.0p, though cash is solid and debt-free.
    Turnaround plan with targets £95.7m · 182% of mcapoutlook positivefirst since Oct 2023 −2.5% on the day
    Moved: new: 2026 earnings recovery – Guided to improvement after weak 2025 · new: Yate closure, Barnsley consolidation – Yate closed; steel operations consolidated at Barnsley

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note